Bellerophon Therapeutics, Inc. Operating Lease Liability
Bellerophon Therapeutics, Inc. had Operating Lease Liability of $0 as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2023-11-14
- 2023-09-30: Operating Lease, Liability $0.00.
- 2023-06-30: Operating Lease, Liability $0.00.
- 2023-03-31: Operating Lease, Liability $8.00K.
- 2022-12-31: Operating Lease, Liability $203.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $203.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $396.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $586.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $773.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $956.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $1.14M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.31M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.49M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.66M 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.83M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.99M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.16M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.32M 10-K · filed 2020-04-06 |
| 2019-09-30 | $2.48M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.29M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.43M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $2.60M 10-Q · filed 2019-11-06 |